Related Experiment Videos
Risk modeling in breast cancer.
1Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390-9155, USA.
The Breast Journal
|February 27, 2004
Summary
Women with BRCA-1 or BRCA-2 gene mutations face higher breast cancer risks. Genetic testing aids risk assessment, but accurate probability determination and counseling are crucial for informed decisions.
Area of Science:
- Oncology
- Genetics
- Preventive Medicine
Background:
- BRCA-1 and BRCA-2 mutations significantly elevate breast cancer risk in women.
- Genetic testing offers insights into this risk and potential interventions.
- The precise absolute breast cancer risk associated with BRCA mutations requires further determination.
Purpose of the Study:
- To evaluate the role of genetic testing and probability estimation in managing breast cancer risk for women with BRCA mutations.
- To highlight the importance of accurate risk assessment and genetic counseling.
Main Methods:
- Review of current guidelines and methodologies for assessing BRCA mutation probability.
- Discussion of the utility and limitations of tools like the BRCAPRO computer program.
- Emphasis on the role of genetic counselors in interpreting test results and guiding patient decisions.
Main Results:
- Current methods for determining BRCA mutation probability are not 100% accurate.
- The BRCAPRO program serves as a valuable tool for probability estimation.
- Limitations in mathematical models necessitate expert interpretation.
Conclusions:
- Genetic testing for BRCA mutations is recommended for women with a >10% probability, per ASCO guidelines.
- Accurate assessment of absolute breast cancer risk is essential.
- Genetic counseling is indispensable for informed decision-making regarding genetic testing and risk-reducing strategies.